Fenwick & West Life Sciences Group
Index
- JPM Conference Takeaways: Biotech and Biopharma Set for Growth in 2018
- Is Digital Health Poised To Grow Or Is It Hitting The Wall?
- Price Transparency And Active Wellness
- USPTO Streamlines International Patent System through Global Patent Dossier Program
- 2012 USPTO Guidance After Mayo v. Prometheus
- Human-Centered Design Key to Adoption for Digital Health Products
- PDUFA Working Its Way Through Capitol Hill
- Aging in Place Drives mHealth Technologies
- Martin Shkreli Convicted on Three of Eight Counts of Securities Fraud
- Federal Circuit: A Biosimilar Applicant Must Provide Notice of Intent to Market a Biosimilar Product, No Exceptions
- 12 Dos And Don’ts For Angel Investors
- Supreme Court Rules to Limit the Types of Methods Eligible for Patenting
- Stickiness Eludes Many Health and Fitness Apps
- Supreme Court Allows Generic Manufacturers to Challenge Use Codes
- Life Science Financing Survey First Half 2012
- Digital Health Investment Trends Q2 2018: Megadeals Become the Norm, China Rising
- Investments in Digital Health Infrastructure Dominate in August
- Will the Supreme Court Review Whether FDA-Mandated Bioequivalence Testing to Maintain Approval Falls Within the § 271(e)(1) Safe Harbor?
- “Clear and Conspicuous” FTC Guidance on Marketing Mobile Apps
- Seeds of Exhaustion: Monsanto Is Coming to the United States Supreme Court
- FDA to Finalize Mobile Medical App Rules Following Bill Passage
- Biosimilars: Supreme Court Grants Certiorari in Amgen v. Sandoz
- A Dynamic Digital Health Sector Means More and Bigger Deals
- Hot Companies In Digital Health
- Strategies For Navigating The Life Sciences Capital Crunch
- Digital Health Companies May Find a Faster Path to Market Under the FDA's Digital Health Plan
- Top Ten Digital Health Investments Of 2013; Generating Momentum For The Year Ahead
- USPTO and EPO Examiners Discuss Key Considerations for Filing Effective Precision Medicine and Bioinformatics Applications in the US and Europe
- More Digital Health Device Makers Expected to Seek FDA Clearance
- Biosimilars: Supreme Court Calls for Solicitor General’s Views in Amgen v. Sandoz
- Digital Health Investments Top $2.6B* in the First Six Months of 2014
- Digital Health Megadeals Get Bigger in Q3 2018
- Big Data Could Save Healthcare System $300+ Billion Annually
- Five Takeaways From Fenwick’s Sixth Annual Digital Health Investor Summit
- The Regulatory Future of mHealth: FCC, FDA and the United States Congress
- Digital Health Investor Summit Highlights Market Potential
- Infrastructure Deals Dominate Digital Health Investment in 2015
- Don’t Miss These 2017 J.P. Morgan Healthcare Conference Events in San Francisco
- Generic Drug Testing “Safe Harbor” Expanded by Recent Court Decision to Include Post-approval Activities Under Hatch-Waxman
- Who Will Pay For Digital Health Apps?
- Investors Make Big Bets on Diagnostics in Q1 2018
- Are Biosimilar Names Key to Biosimilar Fates?
- Health Innovation Summit Begs the Question - Is Digital Health at a Tipping Point?
- Top Trends in H1 2016 Digital Health Investments
- Payer/Provider Digital Health Investments Increase in Q1 2017
- Venture Investment in Digital Health Effectively Doubles in H1 2012
- Digital Health Investors Catch Their Breath in November
- Digital Health Enjoys Tremendous Growth in 2014
- Monetizing Life Science Company Net Operating Losses
- Takeaways from Fenwick’s 2018 Digital Health Investor Summit
- Top Takeaways from Fenwick’s Fifth Annual Digital Health Investor Summit
- Mobile Health Technologies Rake in Largest Digital Health Investments of August
- Digital Health Investments Heat Up In 2014
- Digital Health Investment Maintains Momentum in 2015
- Biosimilars: Solicitor General Recommends Granting Certiorari in Amgen v. Sandoz
- Pricing mobile health apps: Will consumers pay?
- Three Things Tech Titans Have That eHealth Needs
- Digital Health Investments Rack up Another Impressive Month in May
- Investment in eHealth: 2014, and what the future holds
- Patients adopting mobile health faster than doctors
- Testing And Characterizing Biosimilarity: Will The Hatch-Waxman Safe Harbor Apply?
- Life Science Financings Show Uptick in Valuations in 2012 and Increased Activity by Corporate Investors
- The Five Key Questions Every Digital Health Entrepreneur Should Consider
- Jawbone and Oscar Lead Record Breaking Month for Digital Health Financings
- How AI is Transforming Healthcare: Diagnostics, R&D and Therapeutics
- Biotech M&A Surges in Advance of Patent Expirations
- Digital Health Investments Rebound In April
- Digital Health Investment in September Tops $700 Million
- Infrastructure Investments Rule in Q3
- Key Digital Health Investment Trends to Watch
- Will Namenda IR Withdrawal Force A Legal Switch on Product Hopping?
- Which Way to the Exits for Biotech?
- Divestitures and Consolidation in Animal Health Market Present Opportunities to Investors, Innovators
- Life Sciences IPOs Haven’t Slowed in 2019
- Q2 2019: Big Deals in China, Drones and the Return of the Digital Health IPO
- AI in Medical Imaging: Exploring the Frontier of Healthcare Applications
- Key Takeaways from Fenwick’s 2019 Digital Health Investor Summit
- Biotech & Life Sciences Trends to Consider Following JPM 2020: M&A, Venture Capital and More
- Digital Health Investments See Significant Uptick in Q1; Investors Consider COVID-19 Impacts in Coming Months
- COVID-19 Pandemic Shines a Spotlight on Digital Health in Q2 2020
- Digital Health Investors Offer Cautious Optimism at Rock Health H1 2020 Event
- More Consolidation, IPOs Ahead for Digital Health Companies
- Rock Health Summit 2020 Takeaways: Digital Health Is Firing on All Cylinders
- Women Leaders in Digital Health See Rapid Growth and Increased Access Fueled by Pandemic
- Q1 2021 Digital Health Startups Set New Investment Record, Led by On-demand Healthcare, Population Health Management and R&D Tech for Pharma